RISE UP CAMPAIGN LAUNCH
Sickle cell disease impacts over 100,000 people in the US—nearly all of whom are Black/African American. Sickle Cell patients face a harrowing set of challenges: shortened lifespan, excruciating pain crises, overwhelming fatigue, organ damage, bone loss, and to add insult to injury, long-standing systemic racism, healthcare disparities, and emergency room stigma. This population has not only been underrepresented in conversations about their care; they have been left out completely. From this, a Sickle Cell Warrior movement has arisen, demanding change.
Agios Pharmaceuticals came to FCB Health needing to raise awareness about their clinical trial for a promising new sickle cell therapy. To successfully enroll enough participants, Agios needed to build trust amongst the rightfully skeptical Sickle Cell Warrior community. But how do you engage a community that has been pushed to the side for far too long? With RISE UP—a campaign built by and for Sickle Cell Warriors.